Berend J. van der Wilk

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

Ben M. Eyck, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof et al. · Journal of Clinical Oncology · 2021 · 709 citations · Full text

Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial

Berend J. van der Wilk, Ben M. Eyck, Bas P. L. Wijnhoven et al. · The Lancet Oncology · 2025 · 61 citations · Full text

Surgical Oncology, Neoadjuvant Chemoradiotherapy, Esophageal Cancer +12

Outcomes after totally minimally invasive <i>versus</i> hybrid and open Ivor Lewis oesophagectomy: results from the International Esodata Study Group

Berend J. van der Wilk, Eliza Hagens, Ben M. Eyck et al. · British journal of surgery · 2021 · 51 citations · Full text

LBA75 Neoadjuvant chemoradiotherapy followed by surgery versus active surveillance for oesophageal cancer (SANO-trial): A phase-III stepped-wedge cluster randomised trial

Berend J. van der Wilk, Ben M. Eyck, Bas P. L. Wijnhoven et al. · Annals of Oncology · 2023 · 49 citations · Full text

Lba75 Neoadjuvant Chemoradiotherapy, Surgical Oncology, Esophageal Cancer +9

Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study

Xiaobin Zhang, Ben M. Eyck, Yang Yang et al. · BMC Cancer · 2020 · 39 citations · Full text